• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在异种移植模型中,抗血管生成的色素上皮衍生因子可抑制肾母细胞瘤的生长。

Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model.

作者信息

Abramson Lisa P, Stellmach Veronica, Doll Jennifer A, Cornwell Mona, Arensman Robert M, Crawford Susan E

机构信息

Division of Pediatric Surgery, Children's Memorial Hospital, and the Department of Pathology, Northwestern University Medical School, Chicago, Illinois 60611, USA.

出版信息

J Pediatr Surg. 2003 Mar;38(3):336-42; discussion 336-42. doi: 10.1053/jpsu.2003.50104.

DOI:10.1053/jpsu.2003.50104
PMID:12632345
Abstract

BACKGROUND/PURPOSE: Pigment epithelium-derived factor (PEDF), a potent endogenous inhibitor of angiogenesis, is highly expressed in the kidney. The authors postulated that systemic administration of PEDF would decrease Wilms' tumor growth in a xenograft model, and increased renal vascularity would result in a mouse null for PEDF.

METHODS

Tumors were induced in athymic mice using human anaplastic Wilms' tumor cells. Purified PEDF protein or vehicle was administered for 7 days beginning 2 to 3 weeks after inoculation. Tumors were stained with anti-PEDF and anti-Factor VIII antibodies. Mitoses and microvascular density (MVD) were counted per high-power field (hpf). PEDF-null mice were generated on a SV129/C57Bl6 background. Wild-type and null kidneys were assessed for MVD.

RESULTS

Mean tumor weight in the 2-week group was 60% less than controls (P <.05). The MVD and mitotic count in treated tumors were significantly less than controls (P <.05). PEDF stained strongly in normal kidneys but was minimal to absent in Wilms' tumor. PEDF-null kidneys had increased MVD compared with wild-type (P <.05).

CONCLUSIONS

PEDF is expressed strongly in normal murine kidney, and loss of its angioinhibitory activity may contribute to pathologic angiogenesis in Wilms' tumor. Systemic PEDF suppresses WT growth by targeting both the tumor cells and its associated vasculature.

摘要

背景/目的:色素上皮衍生因子(PEDF)是一种强大的内源性血管生成抑制剂,在肾脏中高度表达。作者推测,在异种移植模型中全身给予PEDF会减少肾母细胞瘤的生长,而PEDF基因敲除小鼠的肾血管生成增加。

方法

使用人间变性肾母细胞瘤细胞在无胸腺小鼠中诱导肿瘤形成。接种后2至3周开始,给予纯化的PEDF蛋白或赋形剂,持续7天。用抗PEDF和抗因子VIII抗体对肿瘤进行染色。在每个高倍视野(hpf)中计数有丝分裂和微血管密度(MVD)。在SV129/C57Bl6背景上培育PEDF基因敲除小鼠。评估野生型和基因敲除小鼠肾脏的MVD。

结果

2周组的平均肿瘤重量比对照组减少60%(P<.05)。治疗组肿瘤的MVD和有丝分裂计数明显低于对照组(P<.05)。PEDF在正常肾脏中染色强烈,但在肾母细胞瘤中极少或无染色。与野生型相比,PEDF基因敲除小鼠的肾脏MVD增加(P<.05)。

结论

PEDF在正常小鼠肾脏中强烈表达,其血管生成抑制活性的丧失可能导致肾母细胞瘤中的病理性血管生成。全身给予PEDF通过靶向肿瘤细胞及其相关脉管系统来抑制肾母细胞瘤的生长。

相似文献

1
Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model.在异种移植模型中,抗血管生成的色素上皮衍生因子可抑制肾母细胞瘤的生长。
J Pediatr Surg. 2003 Mar;38(3):336-42; discussion 336-42. doi: 10.1053/jpsu.2003.50104.
2
Pigment epithelium-derived factor targets endothelial and epithelial cells in Wilms' tumor.色素上皮衍生因子作用于肾母细胞瘤中的内皮细胞和上皮细胞。
J Pediatr Surg. 2006 Aug;41(8):1351-6. doi: 10.1016/j.jpedsurg.2006.04.038.
3
Adeno-associated virus vector-mediated delivery of pigment epithelium-derived factor restricts neuroblastoma angiogenesis and growth.腺相关病毒载体介导的色素上皮衍生因子递送可限制神经母细胞瘤的血管生成和生长。
J Pediatr Surg. 2005 Jan;40(1):236-43. doi: 10.1016/j.jpedsurg.2004.09.049.
4
Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth.色素上皮衍生因子可抑制缺血诱导的视网膜新生血管形成以及血管内皮生长因子诱导的迁移和生长。
Invest Ophthalmol Vis Sci. 2002 Mar;43(3):821-9.
5
Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.强效血管内皮生长因子阻断对实验性肾母细胞瘤及其持续存在的脉管系统的影响。
Int J Oncol. 2004 Sep;25(3):549-53.
6
Phosphomimetic mutants of pigment epithelium-derived factor with enhanced antiangiogenic activity as potent anticancer agents.具有增强的抗血管生成活性的色素上皮衍生因子磷酸模拟突变体作为有效的抗癌药物。
Cancer Res. 2010 Aug 1;70(15):6247-57. doi: 10.1158/0008-5472.CAN-10-0434. Epub 2010 Jul 7.
7
Gene transfer of pigment epithelium-derived factor suppresses tumor growth and angiogenesis in a hepatoblastoma xenograft model.色素上皮衍生因子的基因转移在肝母细胞瘤异种移植模型中抑制肿瘤生长和血管生成。
Pediatr Res. 2006 Sep;60(3):282-7. doi: 10.1203/01.pdr.0000232789.86632.91. Epub 2006 Jul 20.
8
Increased microvascular density predicts relapse in Wilms' tumor.微血管密度增加预示着肾母细胞瘤会复发。
J Pediatr Surg. 2003 Mar;38(3):325-30; discussion 325-30. doi: 10.1053/jpsu.2003.50102.
9
Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.色素上皮衍生因子基因疗法可抑制小鼠体内的人类胰腺癌。
Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8737-44. doi: 10.1158/1078-0432.CCR-05-1323.
10
Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.联合抗血管生成疗法:在肾母细胞瘤小鼠模型中疗效增强
J Pediatr Surg. 2001 Aug;36(8):1177-81. doi: 10.1053/jpsu.2001.25747.

引用本文的文献

1
Pigment Epithelial-Derived Factor in Pancreatic and Liver Cancers-From Inflammation to Cancer.胰腺癌和肝癌中的色素上皮衍生因子——从炎症到癌症
Biomedicines. 2024 Oct 4;12(10):2260. doi: 10.3390/biomedicines12102260.
2
Screening of potential hub genes involved in Kidney Wilms tumor via bioinformatics analysis and experimental validation.生物信息学分析和实验验证筛选肾母细胞瘤潜在的关键基因。
BMC Cancer. 2024 Jun 27;24(1):771. doi: 10.1186/s12885-024-12541-x.
3
The Various Roles of PEDF in Cancer.色素上皮衍生因子(PEDF)在癌症中的多种作用。
Cancers (Basel). 2024 Jan 24;16(3):510. doi: 10.3390/cancers16030510.
4
NANO-SBT-PEDF delivery system: A promising approach against ovarian cancer?纳米SBT-PEDF递送系统:对抗卵巢癌的一种有前景的方法?
Heliyon. 2023 Feb 12;9(2):e13676. doi: 10.1016/j.heliyon.2023.e13676. eCollection 2023 Feb.
5
Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy.包裹于纳米颗粒中的抗炎肽对糖尿病性视网膜病变眼部血管渗漏的持续治疗作用
Front Cell Dev Biol. 2022 Dec 16;10:1049678. doi: 10.3389/fcell.2022.1049678. eCollection 2022.
6
Choosing The Right Animal Model for Renal Cancer Research.为肾癌研究选择合适的动物模型。
Transl Oncol. 2020 Mar;13(3):100745. doi: 10.1016/j.tranon.2020.100745. Epub 2020 Feb 22.
7
Malignant ascites: a source of therapeutic protein against ovarian cancer?恶性腹水:一种抗卵巢癌治疗性蛋白质的来源?
Oncotarget. 2019 Oct 15;10(57):5894-5905. doi: 10.18632/oncotarget.27185.
8
Polymorphisms in PEDF linked with the susceptibility to age-related macular degeneration: A case-control study.与年龄相关性黄斑变性易感性相关的PEDF基因多态性:一项病例对照研究。
Medicine (Baltimore). 2018 Aug;97(34):e11981. doi: 10.1097/MD.0000000000011981.
9
Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors.基于丝氨酸蛋白酶抑制剂和α-胰蛋白酶抑制剂的蛋白质抗转移治疗潜力
Cancer Genomics Proteomics. 2018 Jul-Aug;15(4):225-238. doi: 10.21873/cgp.20081.
10
Anti-tumor effects of pigment epithelium-derived factor (PEDF): implication for cancer therapy. A mini-review.色素上皮衍生因子(PEDF)的抗肿瘤作用:对癌症治疗的启示。一篇综述。
J Exp Clin Cancer Res. 2016 Jan 8;35:4. doi: 10.1186/s13046-015-0278-7.